FDA Advisers Back Novavax Vaccine As New U.S. Option

Watch VideoAnother COVID vaccine is nearing the finish line. 

Drugmaker Novavax's vaccine is a two dose shot, given 3 to 8 weeks apart.  

"We do have a problem with vaccine uptake that is very serious in the United States," FDA Center for Biologics Evaluation and Research Director Peter Marks said. "And anything we can...